Patents by Inventor Jon Alexander Schwartz

Jon Alexander Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210307829
    Abstract: Various methods, systems, and devices for treating tissue ablation are disclosed. Some embodiments disclosed herein pertain to methods of treating tumors, systems used for irradiating tissue and tumors with electromagnetic radiation, components and devices of that system, and kits for providing systems used for irradiating tissue and tumors with electromagnetic radiation. In some embodiments, the system provides sub-ablative infrared radiation that is absorbed by nanoparticles. In some embodiments, the nanoparticles absorb the radiation converting it into heat energy. In some embodiments, though the infrared radiation itself may be sub-ablative, the heat energy generated by the nanoparticles is sufficient to cause thermal coagulation, hyperthermia, and/or tissue ablation.
    Type: Application
    Filed: March 30, 2021
    Publication date: October 7, 2021
    Inventors: Glenn Patrick Goodrich, Jon Alexander Schwartz, Andrew Mark Murphy
  • Patent number: 10993769
    Abstract: Various methods, systems, and devices for treating tissue ablation are disclosed. Some embodiments disclosed herein pertain to methods of treating tumors, systems used for irradiating tissue and tumors with electromagnetic radiation, components and devices of that system, and kits for providing systems used for irradiating tissue and tumors with electromagnetic radiation. In some embodiments, the system provides sub-ablative infrared radiation that is absorbed by nanoparticles. In some embodiments, the nanoparticles absorb the radiation converting it into heat energy. In some embodiments, though the infrared radiation itself may be sub-ablative, the heat energy generated by the nanoparticles is sufficient to cause thermal coagulation, hyperthermia, and/or tissue ablation.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: May 4, 2021
    Assignee: Nanospectra Biosciences, Inc.
    Inventors: Glenn Patrick Goodrich, Jon Alexander Schwartz, Andrew Mark Murphy
  • Publication number: 20200155234
    Abstract: Various methods, systems, and devices for treating tissue ablation are disclosed. Some embodiments disclosed herein pertain to methods of treating tumors, systems used for irradiating tissue and tumors with electromagnetic radiation, components and devices of that system, and kits for providing systems used for irradiating tissue and tumors with electromagnetic radiation. In some embodiments, the system provides sub-ablative infrared radiation that is absorbed by nanoparticles. In some embodiments, the nanoparticles absorb the radiation converting it into heat energy. In some embodiments, though the infrared radiation itself may be sub-ablative, the heat energy generated by the nanoparticles is sufficient to cause thermal coagulation, hyperthermia, and/or tissue ablation.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 21, 2020
    Inventors: Glenn Patrick Goodrich, Jon Alexander Schwartz, Andrew Mark Murphy
  • Patent number: 10568693
    Abstract: Various methods, systems, and devices for treating tissue ablation are disclosed. Some embodiments disclosed herein pertain to methods of treating tumors, systems used for irradiating tissue and tumors with electromagnetic radiation, components and devices of that system, and kits for providing systems used for irradiating tissue and tumors with electromagnetic radiation. In some embodiments, the system provides sub-ablative infrared radiation that is absorbed by nanoparticles. In some embodiments, the nanoparticles absorb the radiation converting it into heat energy. In some embodiments, though the infrared radiation itself may be sub-ablative, the heat energy generated by the nanoparticles is sufficient to cause thermal coagulation, hyperthermia, and/or tissue ablation.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 25, 2020
    Assignee: Nanospectra Biosciences, Inc.
    Inventors: Glenn Patrick Goodrich, Jon Alexander Schwartz, Andrew Mark Murphy
  • Publication number: 20190290360
    Abstract: Various methods, systems, and devices for treating tissue ablation are disclosed. Some embodiments disclosed herein pertain to methods of treating tumors, systems used for irradiating tissue and tumors with electromagnetic radiation, components and devices of that system, and kits for providing systems used for irradiating tissue and tumors with electromagnetic radiation. In some embodiments, the system provides sub-ablative infrared radiation that is absorbed by nanoparticles. In some embodiments, the nanoparticles absorb the radiation converting it into heat energy. In some embodiments, though the infrared radiation itself may be sub-ablative, the heat energy generated by the nanoparticles is sufficient to cause thermal coagulation, hyperthermia, and/or tissue ablation.
    Type: Application
    Filed: December 14, 2017
    Publication date: September 26, 2019
    Inventors: Glenn Patrick Goodrich, Jon Alexander Schwartz, Andrew Mark Murphy
  • Patent number: 9211419
    Abstract: Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: December 15, 2015
    Assignees: Nanospectra Biosciences, Inc., Board of Regents, The University of Texas System
    Inventors: Sunil Krishnan, Parmeswaran Diagaradjane, Jon Alexander Schwartz, James Chunjay Wang
  • Publication number: 20130197295
    Abstract: Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy.
    Type: Application
    Filed: January 16, 2013
    Publication date: August 1, 2013
    Applicants: The Board of Regents of the University of Texas System, Nanospectra Biosciences, Inc.
    Inventors: Sunil Krishnan, Parmeswaran Diagaradjane, Jon Alexander Schwartz, James Chunjay Wang
  • Publication number: 20110052672
    Abstract: Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy.
    Type: Application
    Filed: January 16, 2009
    Publication date: March 3, 2011
    Inventors: Sunil Krishnan, Parmeswaran Diagaradjane, Jon Alexander Schwartz, James Chunjay Wang